Opportunity Information: Apply for PAR 13 365

  • The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
  • This funding opportunity was created on Sep 27, 2013 and posted on Sep 27, 2013.
  • Applicants must submit their applications by Nov 1, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education Public housing authorities/Indian housing authorities County governments Public and State controlled institutions of higher education For profit organizations other than small businesses Small businesses City or township governments Independent school districts Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized).
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Apply for PAR 13 365

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The grant opportunity titled "Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18)" (Funding Opportunity Number PAR 13 365) is a National Institutes of Health (NIH) discretionary grant designed to fund research that evaluates real-world, large-scale healthcare policies or delivery programs that are already happening and are expected to affect diabetes prevention or diabetes care. The central idea is to support rigorous evaluation of "natural experiments" in healthcare, meaning policy changes, system reforms, payer initiatives, or major program rollouts that occur outside of NIH funding and create an opportunity to study outcomes before and after implementation, or between groups that were and were not exposed to the change. The emphasis is on generating evidence that can meaningfully inform clinical practice and health policy related to preventing diabetes, improving diabetes treatment, and strengthening diabetes management at the healthcare system level.

A key point of this FOA is what it does not fund: it is not meant to pay for launching new diabetes programs, starting new policy initiatives, or delivering new interventions as part of the grant. Instead, NIH is explicitly supporting the evaluation of policies and programs that are implemented independently of NIH grant funding. In practice, that means applicants need access to an existing or imminent policy or program change (for example, a statewide Medicaid redesign, a health system quality improvement program, value-based payment reforms, coverage expansions, changes in care coordination, or major benefit design changes) and propose a strong research plan to measure how that change influences diabetes-related outcomes. The expectation is that the resulting findings will be actionable, generalizable, and useful to decision-makers, clinicians, and health system leaders.

This opportunity uses the R18 mechanism, which is generally associated with research demonstration and dissemination projects. The funding activity category is listed under Food and Nutrition Health, and the related CFDA number is 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research), indicating alignment with NIH work in diabetes and related conditions. The award ceiling is $500,000 (as listed in the source data), and there is no cost sharing or matching requirement, which reduces barriers for applicants that might not have significant non-federal funds to contribute.

Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants include nonprofit organizations (both 501(c)(3) and non-501(c)(3)), public and private institutions of higher education, state and local governments (including county, city or township, special district governments, and independent school districts), for-profit organizations (including small businesses and other for-profit entities that are not small businesses), and public housing authorities/Indian housing authorities. The FOA also highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), along with faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and eligible federal agencies. At the same time, the announcement is clear that non-U.S. entities are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components are not allowed under NIH policy for this FOA.

In terms of timing and status, the FOA was posted and created on September 27, 2013, with an original and current closing date of November 1, 2016, and an archive date of December 2, 2016. That means the opportunity is archived and no longer accepting applications, but the content remains useful as a reference for understanding NIH priorities around evaluating naturally occurring healthcare reforms that affect diabetes outcomes and for modeling future proposals under similar NIH funding announcements.

For applicants when it was active, the practical takeaway was that a competitive project would have needed (1) a clearly defined external policy or program change affecting healthcare delivery, (2) a credible evaluation design appropriate for a natural experiment (for example, difference-in-differences, interrupted time series, regression discontinuity, stepped-wedge opportunities when implementation is staggered for non-research reasons, or well-constructed comparison groups), (3) reliable access to data sources capable of capturing diabetes-related process and outcome measures (claims, EHR data, registries, quality reporting datasets, or population health data), and (4) a dissemination orientation so the results could influence policy and practice rather than staying purely academic. The announcement’s stated goal is impact: producing evidence that helps stakeholders understand what works in real healthcare settings to prevent diabetes and improve treatment and long-term management.

The sponsoring agency is NIH, and the full announcement was hosted on the NIH grants site at the link provided in the source material. For technical issues accessing the announcement, the listed contact was the NIH Office of Extramural Research (OER) webmaster (FBOWebmaster@OD.NIH.GOV), reflecting that questions were routed through NIH’s general extramural support channels rather than a single program officer contact in the excerpt provided.

Frequently Asked Questions (FAQs)

What is the purpose of the "Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18)" grant?

This funding opportunity supports research that rigorously evaluates real-world, large-scale healthcare policies or delivery programs that are already happening (or imminently happening) and are expected to affect diabetes prevention, diabetes treatment, or diabetes management at the healthcare system level. The goal is to generate evidence that can inform clinical practice and health policy with findings that are useful to decision-makers and health system leaders.

What does "natural experiment" mean in the context of this NIH opportunity?

In this announcement, a natural experiment refers to a policy change, system reform, payer initiative, or major program rollout that occurs outside of NIH funding and creates an opportunity to study outcomes before and after implementation, or between groups that were exposed versus not exposed to the change. The key idea is that the change is driven by the healthcare system or policy environment, not created by the research grant.

What types of healthcare changes were the grant intended to evaluate?

Examples referenced in the opportunity include statewide Medicaid redesigns, health system quality improvement programs, value-based payment reforms, coverage expansions, changes in care coordination, and major benefit design changes. In general, the focus is on large-scale policies or delivery programs that could plausibly affect diabetes-related outcomes.

Does this grant fund the launch of new diabetes programs or interventions?

No. A central feature of this FOA is that it is not meant to pay for launching new diabetes programs, starting new policy initiatives, or delivering new interventions as part of the grant. The NIH support is for evaluating policies and programs that are implemented independently of NIH grant funding.

What is the funding mechanism used by this opportunity?

The opportunity uses the NIH R18 mechanism, which is generally associated with research demonstration and dissemination projects.

What is the Funding Opportunity Number (FON) for this announcement?

The Funding Opportunity Number is PAR 13 365.

Which federal agency sponsors this grant opportunity?

The sponsoring agency is the National Institutes of Health (NIH).

What is the CFDA number associated with this opportunity?

The related CFDA number is 93.847, listed as Diabetes, Digestive, and Kidney Diseases Extramural Research.

What is the funding activity category listed for this grant?

The funding activity category is listed under Food and Nutrition Health.

What is the maximum award amount (award ceiling) indicated for this opportunity?

The award ceiling is listed as $500,000 in the provided source data.

Is cost sharing or matching required?

No. The opportunity indicates there is no cost sharing or matching requirement.

Who was eligible to apply when the opportunity was active?

Eligibility was broad and included many types of U.S.-based organizations and governmental entities. Eligible applicants included:

  • Nonprofit organizations (both 501(c)(3) and non-501(c)(3))
  • Public and private institutions of higher education
  • State and local governments (including county, city or township, special district governments, and independent school districts)
  • For-profit organizations (including small businesses and other for-profit entities that are not small businesses)
  • Public housing authorities/Indian housing authorities

Are minority-serving institutions and community-based organizations included in eligibility?

Yes. The FOA highlights additional eligible applicant categories including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISISs). It also notes faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and eligible federal agencies.

Are non-U.S. (foreign) organizations eligible to apply?

No. The announcement states that non-U.S. entities are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components are not allowed under NIH policy for this FOA.

Is this funding opportunity still open for applications?

No. Based on the provided dates, the FOA is archived and no longer accepting applications.

What were the key dates for this announcement?

The FOA was posted/created on September 27, 2013. The original and current closing date was November 1, 2016, and the archive date was December 2, 2016.

What kind of study designs were encouraged for evaluating these natural experiments?

The opportunity emphasized strong evaluation designs appropriate for natural experiments. Examples mentioned include difference-in-differences, interrupted time series, regression discontinuity, stepped-wedge opportunities when implementation is staggered for non-research reasons, or well-constructed comparison groups.

What types of data sources were expected to support the evaluation?

Applicants were expected to have reliable access to data sources capable of capturing diabetes-related process and outcome measures. Examples listed include claims data, electronic health record (EHR) data, registries, quality reporting datasets, and population health data.

What kinds of outcomes or impacts was the NIH trying to achieve through this FOA?

The stated emphasis is on producing actionable evidence that can meaningfully inform clinical practice and health policy related to preventing diabetes, improving diabetes treatment, and strengthening diabetes management at the healthcare system level. The intent is for results to be useful beyond academia and to support real decision-making by clinicians, policymakers, and health system leaders.

Was dissemination an expectation for projects under this R18?

Yes. The description emphasizes a dissemination orientation so results could influence policy and practice rather than remaining purely academic.

What was a practical checklist for a competitive application (when it was active)?

Based on the provided summary, a competitive project typically would have included:

  1. A clearly defined external policy or program change affecting healthcare delivery
  2. A credible natural-experiment evaluation design (such as difference-in-differences or interrupted time series)
  3. Strong access to data that can measure diabetes-related processes and outcomes (claims, EHRs, registries, etc.)
  4. A plan to disseminate findings in ways that can influence policy and practice

Where was the full announcement hosted?

The full announcement was hosted on the NIH grants site, as referenced in the source material.

Who was listed as the contact for technical issues accessing the announcement?

For technical issues accessing the announcement, the listed contact was the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.

Browse more business programs for Healthcare Providers, Diabetes Research

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Food and Nutrition Health

Next opportunity: Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R18)

Previous opportunity: Urban Waters Small Grants

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 13 365

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 13 365) also looked into and applied for these:

Funding Opportunity
Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R18) Apply for PAR 13 366

Funding Number: PAR 13 366
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $500,000
Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R34) Apply for PAR 13 367

Funding Number: PAR 13 367
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $150,000
Novel Methods for Detection and Measurement of Organ Fibrosis in Kidney, Bone Marrow and Urological Diseases (U01) Apply for RFA DK 13 026

Funding Number: RFA DK 13 026
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $250,000
Biomarkers for Diabetes Complications Non Invasive Measures in the Eye (DP3) Apply for RFA DK 13 027

Funding Number: RFA DK 13 027
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $1,000,000
Limited Competition for the Data Coordinating Center for Type I Diabetes TrialNet (UC4) Apply for RFA DK 13 508

Funding Number: RFA DK 13 508
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
George M. OBrien Urology Cooperative Research Centers Program (U54) Apply for RFA DK 13 020

Funding Number: RFA DK 13 020
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $1,000,000
Seeding Collaborations for Translational Research to Discover and Develop New Therapies for Diseases and Conditions within NIDDKs Mission (Revisions) (R01) Apply for PAR 14 006

Funding Number: PAR 14 006
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $75,000
Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas (SBIR) (R43/R44) Apply for RFA DK 13 028

Funding Number: RFA DK 13 028
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Lead Optimization and Pre Clinical Development of Therapeutic Candidates for Diseases of Interest to NIDDK (STTR (R41/R42)) Apply for PA 14 054

Funding Number: PA 14 054
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Lead Optimization and Pre Clinical Development of Therapeutic Candidates for Diseases of Interest to the NIDDK (SBIR (R43/R44)) Apply for PA 14 055

Funding Number: PA 14 055
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Small Business Technology Transfer Research (STTR) to Develop New Diagnostic, Monitoring and Therapeutics Technologies for the Complications of Type 1 Diabetes (T1D) STTR (R41/R42) Apply for PA 14 059

Funding Number: PA 14 059
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Small Business Innovation Research (SBIR) to Develop New Diagnostic, Monitoring and Therapeutics Technologies for the Complications of Type 1 Diabetes (T1D) (SBIR (R43/R44)) Apply for PA 14 058

Funding Number: PA 14 058
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Research Using Subjects From Selected Type I Diabetes Clinical Studies (Living Biobank) (DP3) Apply for PAR 14 064

Funding Number: PAR 14 064
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3) Apply for PAR 14 065

Funding Number: PAR 14 065
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Cystic Fibrosis Research and Translation Core Center (P30) Apply for RFA DK 13 007

Funding Number: RFA DK 13 007
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $750,000
Systems for Health Apply for RFA 641 14 00002

Funding Number: RFA 641 14 00002
Agency: Ghana USAID Accra
Category: Food and Nutrition Health
Funding Amount: $68,000,000
Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) (U01) Apply for RFA DK 14 501

Funding Number: RFA DK 14 501
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $400,000
Limited Competition Continuation of the Type 2 Diabetes in Adolescents and Youth (TODAY) Study (U01) Apply for RFA DK 14 502

Funding Number: RFA DK 14 502
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $10,000,000
Accelerating Medicines Partnership (AMP) in Type 2 Diabetes (U01) Apply for RFA DK 14 003

Funding Number: RFA DK 14 003
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $300,000
Limited Competition for the Data Coordinating Center of Accelerating Medicines Partnership (AMP) in Type 2 Diabetes (U01) Apply for RFA DK 14 503

Funding Number: RFA DK 14 503
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $2,500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 365", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.